In its court filing, the company said Twist Founder and CEO Emily LeProust stole its technology and breached her confidentiality agreements.
The company has sued three companies in the UK and two in Poland alleging they infringed on the firm's non-invasive prenatal testing patents.
Agilent will pay Enzo $9 million to settle the suit, which involved a US patent issued to Enzo and describing non-porous solid supports for nucleic acids.
The company exited the NGS whole-genome analysis market a few years ago and is now focused on building a business around its core IP search technology.
Hologic said in its Form 10-Q that Enzo sued the firm in March alleging infringement of a patent related to labeled nucleotides for use as diagnostic tools.
The appeals court reversed in part an earlier decision by aUSdistrict court that resulted in a $61 million award to Enzo, and remanded the case back to the district court.
Illumina and its subisidiary Verinata allege Premaitha's Iona test infringes two European patents relating to the use of cell-free fetal DNA for NIPT.
Several early-access customers presented results from the 10X technology at the meeting.
The IP covers the detection of histone modifications in cell-free nucleosomes from circulating cancer cells.
In a statement to GenomeWeb, Myriad noted that all seven of its cases are now settled, "which ends the BRCA litigation."
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.